Michael P. Tarnok

Entity
Individual
Business address
Keryx Biopharmaceuticals, Inc., 750 Lexington Avenue, 10022 New York, NY
Phone
(212) 531-5965
Signature Ownership
/s/ Ping Rawson, attorney-in-fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Michael P. Tarnok has filed 30 SEC EDGAR filings since 9/26/2007

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Jun 24, 2025 Jun 20, 2025 001-32513
4 Open Document Open Filing FORM 4 Jan 7, 2025 Jan 2, 2025 001-32513
4 Open Document Open Filing FORM 4 Nov 25, 2024 Nov 22, 2024 001-32513
4 Open Document Open Filing FORM 4 May 23, 2024 May 21, 2024 001-32513
4 Open Document Open Filing FORM 4 Apr 15, 2024 Apr 11, 2024 001-32513
4 Open Document Open Filing FORM 4 Jan 4, 2024 Jan 2, 2024 001-32513
4 Open Document Open Filing FORM 4 Jan 5, 2023 Jan 3, 2023 001-32513
4 Open Document Open Filing FORM 4 Jun 14, 2022 Jun 10, 2022 001-32513
4 Open Document Open Filing FORM 4 Jan 5, 2022 Jan 3, 2022 001-32513
4 Open Document Open Filing FORM 4 Jan 6, 2021 Jan 4, 2021 001-32513
4 Open Document Open Filing FORM 4 Jan 3, 2020 Jan 2, 2020 001-32513
4 Open Document Open Filing FORM 4 Jun 27, 2019 Jun 25, 2019 001-32513
3 Open Document Open Filing FORM 3 Feb 13, 2019 Feb 12, 2019 000-55264
4 Open Document Open Filing FORM 4 SUBMISSION Jun 18, 2015 Jun 17, 2015 000-30929
4 Open Document Open Filing FORM 4 SUBMISSION May 6, 2015 May 6, 2015 000-30929
4 Open Document Open Filing FORM 4 SUBMISSION Jun 26, 2014 Jun 24, 2014 000-30929